[go: up one dir, main page]

MX2022003090A - Vacuna combinada para ser administrable intradermicamente. - Google Patents

Vacuna combinada para ser administrable intradermicamente.

Info

Publication number
MX2022003090A
MX2022003090A MX2022003090A MX2022003090A MX2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A MX 2022003090 A MX2022003090 A MX 2022003090A
Authority
MX
Mexico
Prior art keywords
mhyo
pcv2
relates
vaccine
administrable
Prior art date
Application number
MX2022003090A
Other languages
English (en)
Inventor
Theodorus Jansen
Maarten Hendrik Witvliet
Melanie Sno
Martin Piest
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2022003090A publication Critical patent/MX2022003090A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere al campo de la vacunología veterinaria, a saber, a vacunas combinadas para cerdos. En términos particulares, la invención se refiere a una vacuna combinada para la protección contra una infección patógena con circovirus porcino tipo 2 (PCV2) y Mycoplasma hyopneumoniae (Mhyo) que comprende un inmunógeno no replicante de PCV2 e inmunógeno no replicante de Mhyo. La vacuna se caracteriza porque es una emulsión de aceite en agua que comprende escualano, vitamina E-acetato y sílice. En otra modalidad, la invención se refiere a una vacuna combinada para la protección contra una infección patógena con PCV2 y Mhyo mediante administración intradérmica.
MX2022003090A 2019-09-12 2020-09-11 Vacuna combinada para ser administrable intradermicamente. MX2022003090A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19196890 2019-09-12
PCT/EP2020/075454 WO2021048338A1 (en) 2019-09-12 2020-09-11 Combination vaccine for intradermal administration

Publications (1)

Publication Number Publication Date
MX2022003090A true MX2022003090A (es) 2022-04-11

Family

ID=68136125

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003090A MX2022003090A (es) 2019-09-12 2020-09-11 Vacuna combinada para ser administrable intradermicamente.

Country Status (9)

Country Link
US (1) US20220323567A1 (es)
EP (1) EP4028050A1 (es)
JP (2) JP2022548001A (es)
KR (1) KR20220062345A (es)
CN (1) CN114364398B (es)
BR (1) BR112022004256A2 (es)
CA (1) CA3149027A1 (es)
MX (1) MX2022003090A (es)
WO (1) WO2021048338A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4452315A1 (en) 2021-12-24 2024-10-30 Intervet International B.V. Stable emulsions of antigens
WO2024235713A1 (en) 2023-05-12 2024-11-21 Intervet International B.V. A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus
WO2024235714A1 (en) 2023-05-12 2024-11-21 Intervet International B.V. A vaccine against leptospira bacterium
WO2024235705A1 (en) 2023-05-12 2024-11-21 Intervet International B.V. A combination vaccine against erysipelothrix rhusiopathiae, porcine parvo virus and leptospira bacterium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2389506C2 (ru) 2005-09-09 2010-05-20 Интервет Интернэшнл Б.В. Вакцина против рсv-2
DK2371383T3 (en) 2005-12-29 2015-11-30 Boehringer Ingelheim Vetmed Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs
DK2481420T3 (da) 2006-12-15 2019-05-06 Boehringer Ingelheim Animal Health Usa Inc Enkeltdosis-anti-PCV2-svinevaccine
CN106999567B (zh) * 2014-12-11 2021-08-31 英特维特国际股份有限公司 用于即用型PCV2/M.hyo组合疫苗的方法
BR112018069100A2 (pt) * 2016-03-23 2019-01-29 Intervet International B.V. uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae
MX388128B (es) * 2016-12-23 2025-03-19 Intervet Int Bv Vacuna combinada para cerdos.
JP7510874B2 (ja) * 2017-12-22 2024-07-04 ヒプラ シエンティフィック エセ．エレ．ウ． マイコプラズマ及びブタサーコウイルスに対する皮内混合ワクチン

Also Published As

Publication number Publication date
WO2021048338A1 (en) 2021-03-18
BR112022004256A2 (pt) 2022-06-21
US20220323567A1 (en) 2022-10-13
KR20220062345A (ko) 2022-05-16
EP4028050A1 (en) 2022-07-20
CA3149027A1 (en) 2021-03-18
CN114364398A (zh) 2022-04-15
JP2022548001A (ja) 2022-11-16
CN114364398B (zh) 2025-08-22
JP2025106086A (ja) 2025-07-11

Similar Documents

Publication Publication Date Title
MX2022003090A (es) Vacuna combinada para ser administrable intradermicamente.
RU2434638C2 (ru) Вакцина альфа токсоида с.perfringens
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
MX388128B (es) Vacuna combinada para cerdos.
MX2010005014A (es) Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
MX2010007815A (es) Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
GT200200138A (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
BR112018069100A2 (pt) uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
AR108829A1 (es) Vacuna contra virus de bronquitis infecciosa
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
JP2019509300A5 (es)
RU2018127403A (ru) Поливалентная вакцина против hyo и ее применение
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
BR112014023283A8 (pt) Composição imunogênica, segunda composição imunogênica, e, método para prevenção e/ou tratamento contra doença influenza
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas
BRPI0608310A2 (pt) uso de um poxvìrus modificado para a indução rápida de imunidade contra um poxvìrus ou outros agentes infecciosos
MX390682B (es) Vacunas que contienen patogenos de cerdo para uso no mixto asociado.
MX2023005049A (es) Vacuna combinada para proteger a los cerdos contra diversos trastornos.
MX2022000525A (es) Vacunas contra la ehrlichia y composiciones inmunogenicas.
DK1387693T3 (da) Saponininaktiveret mykoplasmavaccine
RU2018137033A (ru) Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs
MX388528B (es) Vacuna que comprende toxoides de clostridium.
BR112023002804A2 (pt) Vacinas para covid-19 com adjuvantes em emulsão de esqualeno contendo tocoferol
MX2021010194A (es) Vacunas contra la influenza multivalentes adyuvantadas.